SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Discussion centers on reports that Supermicro is shipping NVIDIA Vera Rubin rack-scale systems to SpaceXAI, fueling optimism about large AI-infrastructure deployments and renewed demand for its servers. Bulls see a breakout or short squeeze ahead, while skeptics point to repeated resistance, volatile trading and concerns about margins and execution.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Anticipation around Infleqtions Quantum World Congress keynote and Impact 250 engagements is driving discussion, with traders speculating about a 30-logical-qubit milestone or other technical and government updatesnone of those hoped-for announcements is confirmed. Sentiment is largely bullish but tempered by frustration over volatile, range-bound trading, while IonQs progress is also cited as a boost for the quantum sector.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

A strong semiconductor-sector rally and rotation into chips, supported in traders discussion by ongoing AI and memory demand, is driving attention. Dip-buying and breakout optimism are competing with warnings of overextension, macro risks, and bearish bets including Michael Burrys reported SOXX short additions.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms launch of two 2nm Snapdragon flagship chips focused on on-device AI is driving discussion, with traders viewing the products as a potential growth lever beyond smartphones. Reactions are mostly bullish, though some are questioning Samsungs visibility among the launch partners.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Analyst upgrades citing Azure and AI growth, alongside confidence in cost discipline, are a major focus; traders are debating whether the positive outlook can overcome repeated rejection at a key round-number resistance level. Xbox job cuts and restructuring add a counterpoint, while reactions to the stocks choppy performance remain mixed.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally to record highs and a $1 trillion market value is being tied to renewed AI-chip demand expectations, particularly around Metas Muse AI and the computing needs of agentic workloads. Bulls see continued momentum and demand for AMD CPUs and accelerators, while skeptics warn the sharp run has left the stock overbought and valuation, dilution, and profit-taking risks are rising.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention as traders await the final analysis of its Phase 3 REGAL trial of GPS in AML, with the still-unreported 80th overall-survival event fueling bullish hopes of durable benefit and skepticism that the delay proves efficacy. Upcoming SLS009 research presentations are a secondary catalyst, while speculation about a buyout remains unconfirmed.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs sharp, high-volume rally is drawing speculation around ImmunityBio founder Patrick Soon-Shiongs meeting with Turkeys president, with traders anticipating a possible Anktiva expansion there despite no confirmed deal. The conversation also focuses on potential stock tokenization and short-squeeze dynamics, while skeptics say the move lacks a confirmed company catalyst.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

NVAXs recent strength is being linked by traders to Modernas biotech and oncology rally, alongside anticipation of preclinical oncology updates involving Novavaxs Matrix-M adjuvant and an undisclosed pharma partner. Many bullish posts point to high short interest as potential fuel, while skeptics say the move lacks a confirmed new deal or company catalyst.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is drawing attention after VK2735 data showed patients retained most of their weight loss on less-frequent maintenance injections, alongside continued weight loss in the weekly-dosing group; traders also point to analyst upgrades as support for the sharp rally. Many are bullish on the drugs potential in the obesity market, while debate continues over the early-stage data, competition, possible dilution and unconfirmed buyout speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Carisma Announces Delisting from Nasdaq and SEC Deregistration

Carisma Announces Delisting from Nasdaq and SEC Deregistration Carisma Announces Delisting from Nasdaq and SEC Deregistration PR Newswire PHILADELPHIA, Dec. 5, 2025 PHILADELPHIA, Dec. 5, 2025...

JPM downgrades Avis Budget after stock rally on recall, tariff impact

Investing.com -- JP Morgan downgraded  Avis Budget  (NASDAQ:CAR) Group to Neutral from Overweight, saying the stock’s sharp rally since March has outpaced the underlying earnings outlook, while near-term pressures from safety recalls and fading tariff tailwinds weigh on estimates.

These companies are most likely to surprise in real estate H1 earnings season

Investing.com -- Bernstein expects a mixed but potentially positive first-half earnings season for the European real estate sector, highlighting nine companies that could raise their guidance.

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Carisma Therapeutics Inc

Neutral Sentiment

Job displacement

Market bubble / overvaluation

Loss of human oversight / control

Killer robots 🤖

As AI spending accelerates across hyperscalers and valuations climb to historic highs, investors and workers alike are increasingly debating the risks the technology poses - from job displacement to fears about losing human oversight over increasingly autonomous systems. What do you think is the biggest threat AI poses? Vote and explain your reasoning in the comments.

Current Price	$0.0011
Prev Close	$0.0007
Open	$0.0007
Dividend Yield	N/A
50-Day Moving Average	$0.0023
Beta	5.91
Avg. Volume	15,560.14
PE Ratio	0.01

52-Week High	$0.299
52-Week Low	$0.0001
Market Capitalization	$29,292.00
EPS (Annual)	N/A
Price to Book	-0.05
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

CARM Fundamentals